Jump to content

  • Set Your Location
  • Sign in or Enroll
Set Your LocationSet Your Location
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Patient Stories
  • Clinical Research Gives Boost to Melanoma Survivor
Content

PATIENT STORIES Clinical Research Gives Boost to Melanoma Survivor

Clinical research advancing care for melanoma patients at Sutter Health

California Pacific Medical Center

The Camino de Santiago is an epic 500-mile pilgrimage to the Spanish city of Santiago de Compostela, tracing the base of the French Pyrenees to Santiago de Compostela in northwestern Spain.

We are committed to leading research that advances care for our patients.
Laura Clausen and her daughter Katelyn trekking in Spain

Seven years ago, the trek wasn’t even a fleeting thought for Laura Clausen, never mind presenting its first steps to her this year. In September, Laura and her daughter hiked 100 miles of the journey over two weeks. They assisted people in wheelchairs complete the journey as part of an inaugural, accessible Camino event inspired by the documentary and true-life story, I’ll Push You.

A melanoma survivor at age 63, Laura has already steadfastly climbed her own cancer journey-related peaks, and weathered the ups and downs of countless tests, procedures and treatments.

After her shift one day in 2012 as a surgical technologist in operating rooms at Stanford Hospital, the Palo Alto resident discovered a grape-sized lump on her neck. A prompt biopsy and CT scans revealed stage 4 melanoma—the deadliest form of skin cancer. One week later, she had surgery to remove the tumor in her neck and several cancerous lesions that had spread to her lungs and armpit region.

“Nothing can prepare you for the initial shock, disbelief, and grief,” says Laura, who underwent almost immediate courses of chemotherapy, radiation therapy, three surgeries, and interleukin 2 (a type of immunotherapy) to kill the cancerous cells. After no regression of her tumor, treatment with ipilimumab—a targeted therapy for melanoma and other cancers—was also ineffective in stopping the metastases from spreading.

Her oncologist at Stanford Hospital told Laura about a new clinical trial for people with advanced melanoma being offered at Sutter’s California Pacific Medical Center (CPMC). Study participants in the trial would receive an investigational, targeted immunotherapy called nivolumab to treat their cancer. At that time, CMPC was the only site in Northern California offering the trial.

“I had never dreamed that something so deadly could be happening to me,” says Laura. “I had exhausted all treatment options. Enrolling in the clinical trial presented a way for me to have some semblance of control, with the hope and proactive stance to reprogram my life in 10-day increments with each infusion.”

After similar clinical trials of the drug across the U.S. had positive results, nivolumab was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of melanoma. Marketed under the brand name Opdivo®, the drug’s tumor-shrinking effects prompted researchers worldwide to study it in other cancers, and similar FDA approvals followed over the next four years for treating cancers of the lung, colorectum, liver, bladder, and kidney, as well as Hodgkin’s lymphoma.

“Targeted and immunotherapies offer exciting potential in improving outcomes for our patients,” says David Minor, MD, who enrolled Laura into the first clinical trial of nivolumab at CPMC. “We are committed to leading research that helps guide and inform the treatment path for patients like Laura whose cancers have been unresponsive to standard-of-care approaches.”  Dr. Minor, Associate Director of CPMC’s Center for Melanoma Research and Treatment, is known nationwide for leading clinical trials of immunotherapy and targeted therapies for advanced and metastatic cancers.

Collaborating with CPMC oncologist and melanoma expert Kevin Kim, MD, Dr. Minor was stunned by Laura’s response to treatment. “After one year, Laura’s tumors disappeared. Because of the success of the drug nivolumab in treating Laura’s cancer and the cancer of other patients like her, the data from this trial led to FDA approval of the drug in 2014.

Since then, nivolumab has been approved for eight additional types of cancer, and has been life-saving for thousands of individuals,” says Dr. Minor. CPMC was a trial site for the pivotal study of nivolumab and was one of the top enrolling sites to the trial across Northern California.

Laura has remained symptom-free since 2014 and her tumors have continued to shrink. She comes to CPMC’s Pacific Heights campus for infusions of the drug every two weeks, and Dr. Kim monitors her response to therapy.

Laura has complemented her treatment with lifestyle changes including stress reduction, meditation, physical activity and dietary modifications. Reading positive affirmations daily and books such as Kelly Turner’s Radical Remission, The Nine Key Factors That Can Make a Real Difference have been a game-changer along the way.

“The most significant factor for me has been a desire to help others and to share my story,” says Laura. “When there is meaning in your life, you become full of peace overflowing to every aspect of your life and opening up endless possibilities.” Seven years ago, a clinical trial was one possibility that presented itself. Now, she has already seen the beautiful vistas of the Camino de Santiago.

Related Stories

Study Shines Light on COVID-19 Racial Disparities

Our health equity research means implementing change models not only inside Sutter, but also help to influence equitable care well beyond our network.

Philanthropy Supports Cancer Complementary Services in Modesto

Bike store owner Brian Zahra describes why he's passionate about donating time and money to the Cancer Complementary Therapies program at MMC.

Leaders, Communities & Team Welcome Early Opening of SRMC

Sutter Roseville Medical Center welcomes the first patients to its newly expanded emergency and intensive care units.

Kidney Cancer-Free After Minimally Invasive Surgery

After his doctors discovered a golf ball-sized tumor on his kidney, Melvin had minimally invasive surgery and is now cancer-free.

Your Gifts in Action at PAMF

Unrestricted gifts fund innovative programs across PAMF.

See all Patient Stories

Disclaimer

Each individual’s treatment and/or results may vary based upon circumstances and the healthcare provider’s medical judgment. Testimonials or statements made by any person(s) within this site are not intended to guarantee outcomes or substitute for medical advice.

The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

  • Contact Us
  • Find Doctors
  • Find Locations
  • Request Medical Records
  • Make a Gift
Sign in to My Health Online

Billing and Insurance

  • Pay a Bill
  • Accepted Health Plans
  • Estimate Costs
  • Medicare Advantage

About Sutter

  • About Our Network
  • Community Benefit
  • Annual Report
  • News

Our Team

  • For Employees
  • For Medical Professionals
  • For Vendors
  • For Volunteers

Careers

  • Jobs at Sutter
  • Physician Jobs
  • Graduate Medical Education

Copyright © 2023 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

  • ADA Accessibility
  • Privacy
  • Do Not Sell My Personal Information
  • LinkedIn Opens new window
  • YouTube Opens new window
  • Facebook Opens new window
  • Twitter Opens new window
  • Instagram Opens new window
  • Glassdoor Opens new window

Cookie Policy

We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

Privacy Policy Cookie Preferences